600.x to become 600.xx: New fifth digit will clarify prostate hyperplasia

Why This Topic Matters

The article matters because it identifies diagnosis coding changes that can affect claim acceptance, medical necessity support, and how urology services are documented for payment. It also highlights procedural and payer-policy considerations that may influence reimbursement for urinary incontinence treatments.

Article Sections

1. ICD-9 prostate hyperplasia code revisions

   Covers the diagnosis code update affecting prostate hyperplasia and the transition from older categories to more specific reporting options. The section focuses on the overall nature of the ICD-9 revision and its timing.

2. Additional ICD-9 urology code changes

   Summarizes other diagnosis code changes relevant to urology, including updates related to penile conditions, urgency, and trauma. It also references the implementation timing and the source of the code changes.

3. Proof of other failed treatments needed before billing for implants

   Discusses general payer and documentation considerations for urinary incontinence implant procedures and periurethral bulking agents. The section addresses coverage criteria, testing, and broader clinical context without detailing decision rules.